Table 3.
Concentration of WE (µg/mL) | Cell viability ± SD (%) |
Inhibition ± SD (%) |
IC50 ± SD value of WE |
||||||
---|---|---|---|---|---|---|---|---|---|
HeLa | SiHa | CaSki | HeLa | SiHa | CaSki | HeLa | SiHa | CaSki | |
50 | 78.19±6.75b | 81.57±7.67b | 74.12±6.89b | 21.81±2.34f | 18.43±1.75e | 25.88±2.59f | 220.34±17.23 | 248.21±19.67 | 152.66±11.44 |
100 | 68.67±6.12c | 73.88±6.99b | 62.24±5.90c | 31.33±3.11e | 26.12±2.34d | 37.76±3.65e | |||
150 | 61.44±6.11c | 56.10±5.58c | 50.77±4.98d | 38.56±3.78d | 34.19±3.90c | 49.23±4.15d | |||
200 | 53.11±4.22d | 61.00±6.01c | 42.24±4.78e | 46.89±4.89c | 39.00±4.02c | 57.76±4.90c | |||
250 | 32.10±3.87e | 48.77±4.05d | 24.44±2.35e | 67.90±6.01b | 51.23±5.56b | 75.56±6.45b | |||
Control (negative) | 100a | 100a | 100a | 0 | 0 | 0 | |||
Positive control (Adriamycin 5µg/mL) | 1.09±0.55f | 1.89±0.65e | 0.11±0.66f | 98.91±9.22a | 98.11 ±9.17a | 99.89 ±10.12a |
Note: Each data is Mean± SD (p<0.05) of three independent experiments. Same letter in the same row indicates statistically no different but different letter indicates they are statistically different as per Duncan analysis (p=0.05 level)